First leukaemia patient to get pioneering drug on NHS says it is 'very sci
BBC • • world
Key Points:
- Oscar Murphy, the first leukaemia patient to receive CAR-T therapy on the NHS, described the treatment as "fantastic" and "very sci-fi," highlighting its potential to rapidly target and destroy aggressive cancer cells.
- CAR-T therapy involves reprogramming a patient's own immune cells to recognise and attack cancer, offering a safer and more effective alternative to traditional treatments for B-cell acute lymphoblastic leukaemia (B-cell ALL).
- Clinical trials showed a 77% remission rate with CAR-T therapy, extending patients' lives by an average of 15.6 months, and NHS England plans to offer this treatment to around 50 patients annually at multiple centres across England.
- The treatment, developed by UK-based company
